Sign in
Taking people in United StatesNo phase

A Special Diet to Help Manage Ulcerative Colitis

Tests a high protein, high fiber diet in adults with ulcerative colitis.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Microbiome-targeted Diet Therapy in Ulcerative Colitis
Status
Recruiting
People taking part
40 people, planned
Started
4 Nov 2026
Expected to end
1 Jun 2029
Type of study
Interventional
Treatments tested
  • High Protein, High Fiber (HPHF) Diet
Record updated
9 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with mild ulcerative colitis to test a high-protein, high-fiber diet.

Age
18 years or older
Sex
All sexes can join
Disease stage
Ulcerative colitis diagnosed by symptoms and endoscopy, lasting at least 3 months, with an endoscopic severity score (UCEIS) of 4 or lower within 90 days before randomization. Moderate or severe disease (UCEIS 5 or higher) cannot join.
Earlier treatment
Stable dose of UC treatment, or no treatment apart from steroids: at least 4 weeks if no medication or 5-ASA, at least 8 weeks for immunomodulatory therapy, at least 12 weeks for biologics.

Main reasons for not taking part

  • Stomach surgery or bowel resection in the past
  • Antibiotic use within 3 months, or antibiotics expected during the study
  • Pregnancy or breastfeeding
  • Anaphylactic food allergies or intolerance of high dietary fiber
  • Habitual vegan diet, or ongoing alcohol or drug abuse

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Ability and willingness to provide informed consent
  • Age at least 18 years old
  • Diagnosis of UC based on clinical and endoscopic criteria
  • UC duration of at least 3 months
  • Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score ≤4 within 90 days of randomization
  • On a stable dose or no existing UC therapies (apart from steroids) for defined periods (as outlined below); ≥4 weeks if no medication, 5-ASA; ≥8 wk for immunomodulatory therapy; ≥12 wk for biologics
  • Ability to comply with study requirements in the opinion of the primary investigator

Who cannot take part

  • Ongoing alcohol or drug abuse
  • History of stomach surgery or bowel resection
  • History of anaphylactic food allergies
  • Moderate or severe UC as defined by UCEIS ≥5
  • Antibiotic use within 3 months
  • Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)
  • Pregnancy or breastfeeding
  • Intolerance of high dietary fiber content
  • Habitual vegan diet pattern
  • Insufficient freezer space to accommodate meal delivery

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Levi TeigenTaking people

About the trial

What the trial wants to find out

The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.

The group in the trial

  • On-Off Cycling InterventionTreatment being tested

    1 week standard diet, followed by 1 week high-protein, high-fiber diet, followed by 1 week standard diet, followed by 1 week high-protein, high-fiber diet

    Treatment: High Protein, High Fiber (HPHF) Diet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Microbiome-targeted Diet Therapy in Ulcerative Colitis
Plain-language title
A Special Diet to Help Manage Ulcerative ColitisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
9 November 2026